Extended Research Article
Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation
Mark Corbett
,
Fadi Chehadah
,
Mousumi Biswas
,
Thirimon Moe-Byrne
,
Stephen Palmer
,
Marta Soares
et al.
-
Journal:
Health Technology Assessment Volume: 21, Issue: 56
-
Published:
4 October 2017